Home / Resource Library / Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Article discusses the 10 year follow up of a study involving allogeneic stem cell transplant outcomes in patients with relapsed/refractory CLL.